We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$697M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+16.16%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$179M
AUM Growth
+$7.38M
(+4.3%)
Cap. Flow
-$6.1M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
57.08%
Holding
70
New
27
Increased
8
Reduced
10
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$11.5M |
| 2 |
Biogen
BIIB
|
+$7.82M |
| 3 |
Puma Biotechnology
PBYI
|
+$5.84M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$4.59M |
| 5 |
GSK
GSK
|
+$3.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$5.98M |
| 2 |
Edwards Lifesciences
EW
|
+$5.15M |
| 3 |
Zimmer Biomet
ZBH
|
+$4.82M |
| 4 |
Aclaris Therapeutics
ACRS
|
+$3.76M |
| 5 |
NTUS
Natus Medical Inc
NTUS
|
+$3.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 64.1% |
| 2 | Industrials | 3.12% |
| 3 | Financials | 2.65% |
| 4 | Technology | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
PUT
Amgen
AMGN
$212B
| – | – |
-30,000
| Closed | -$4.39M |
|
52
Actinium Pharmaceuticals
ATNM
$27.2M
| – | – |
-54,969
| Closed | -$1.44M |
|
53
CALL
Boston Scientific
BSX
$68.5B
| – | – |
-120,500
| Closed | -$2.61M |
|
54
PUT
Cardinal Health
CAH
$54.5B
| – | – |
-70,000
| Closed | -$5.04M |
|
|
55
Edwards Lifesciences
EW
$48.2B
| – | – |
-165,000
| Closed | -$5.15M |
|
|
56
CALL
GSK
GSK
$108B
| – | – |
-136,000
| Closed | -$6.55M |
|
57
PUT
Humana
HUM
$46.7B
| – | – |
-12,500
| Closed | -$2.55M |
|
58
CALL
Philips
PHG
$25B
| – | – |
-135,056
| Closed | -$3.06M |
|
59
Perrigo
PRGO
$1.43B
| – | – |
-29,329
| Closed | -$2.44M |
|
|
60
PUT
Sanofi
SNY
$109B
| – | – |
-210,000
| Closed | -$8.49M |
|
61
PUT
Sarepta Therapeutics
SRPT
$1.63B
| – | – |
-35,000
| Closed | -$960K |
|
62
PUT
Stryker
SYK
$133B
| – | – |
-20,000
| Closed | -$2.4M |
|
|
WBA
63
PUT
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-57,000
| Closed | -$4.72M |
|
|
64
Zimmer Biomet
ZBH
$18.5B
| – | – |
-48,125
| Closed | -$4.82M |
|
65
PUT
Zoetis
ZTS
$32.5B
| – | – |
-80,000
| Closed | -$4.28M |
|
|
NTUS
66
DELISTED
Natus Medical Inc
NTUS
| – | – |
-90,865
| Closed | -$3.16M |
|
|
HRC
67
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| – | – |
-106,594
| Closed | -$5.98M |
|
|
ADMS
68
DELISTED
Adamas Pharmaceuticals
ADMS
| – | – |
-69,215
| Closed | -$1.17M |
|
|
IMMU
69
DELISTED
Immunomedics Inc
IMMU
| – | – |
-506,978
| Closed | -$1.86M |
|
|
AGN
70
PUT
DELISTED
Allergan plc
AGN
| – | – |
-20,000
| Closed | -$4.2M |
|
Similar funds
GUB
KLI
JA
WIC
AAM
TCM
CA
SAM
Sio Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Sio Capital Management held 70 positions worth $179M, up 4.3% from $171M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Sio Capital Management withdrew a net $6.1M in Q1 2017, closing 24 positions and reducing 10 holdings. Its most notable exit was HILL-ROM HOLDINGS, INC., an estimated $5.98M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 44% a quarter earlier, followed by Industrials and Financials.
Against the trend, Sio Capital Management opened a new position in Sanofi worth $12.2M.
- Sio Capital Management's largest Q1 2017 buy was Sanofi: 270,422 shares worth $12.2M.
- Sio Capital Management added most to GSK in Q1 2017, an estimated $3.28M increase.
- Sio Capital Management's biggest Q1 2017 reduction was Advanced Accelerator Applications S.A., cutting an estimated $1.55M.
- Sio Capital Management fully exited HILL-ROM HOLDINGS, INC. in Q1 2017, selling an estimated $5.98M.
- Sio Capital Management's ten largest holdings make up 57% of its $179M portfolio in Q1 2017.
- Sio Capital Management opened 27 new positions and closed 24 in Q1 2017.
- Sio Capital Management's portfolio value rose 4.3% quarter-over-quarter to $179M.
Based on Sio Capital Management's 13F filing for Q1 2017, filed 15 May 2017.